Specific focus was on two representative cell lines, Mia-Paca2 and Panc89, originating from different stages and tissues of human pancreatic tumors and reacting to CDK7 inhibition with distinct sensitivity. The gene discussed is CDK7; the disease is pancreatic neoplasm.